Efficacy of IL-6 antagonists in the treatment of COVID-19 patients: further randomized controlled trials are warranted

Detalles Bibliográficos
Autores principales: Panda, Aditya K., Padhi, Sunali, Pati, Abhijit, Nayak, Tapan Kumar Singh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442637/
https://www.ncbi.nlm.nih.gov/pubmed/34524645
http://dx.doi.org/10.1007/s13577-021-00616-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442637/
https://www.ncbi.nlm.nih.gov/pubmed/34524645
http://dx.doi.org/10.1007/s13577-021-00616-x

Ejemplares similares